Equifax's (EFX) Buy Rating Reiterated at Needham & Company LLC

Equifax (NYSE:EFX - Get Free Report)'s stock had its "buy" rating reiterated by stock analysts at Needham & Company LLC in a report released on Thursday, Benzinga reports. They presently have a $305.00 price objective on the credit services provider's stock. Needham & Company LLC's price objective would indicate a potential upside of 40.22% from the company's current price.

Several other research analysts also recently commented on the stock. Truist Financial lifted their price target on shares of Equifax from $270.00 to $285.00 and gave the stock a "buy" rating in a research note on Friday, February 9th. Stifel Nicolaus lifted their target price on shares of Equifax from $208.00 to $289.00 and gave the stock a "buy" rating in a research note on Tuesday, January 9th. Bank of America raised shares of Equifax from an "underperform" rating to a "buy" rating and lifted their target price for the stock from $164.00 to $300.00 in a research note on Monday, January 8th. TheStreet raised shares of Equifax from a "c+" rating to a "b-" rating in a research note on Friday, December 29th. Finally, Oppenheimer lifted their target price on shares of Equifax from $273.00 to $291.00 and gave the stock an "outperform" rating in a research note on Tuesday, April 9th. Four equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat.com, Equifax presently has an average rating of "Moderate Buy" and a consensus price target of $267.00.

Equifax Stock Down 8.5 %

Shares of EFX stock traded down $20.17 on Thursday, hitting $217.51. The stock had a trading volume of 3,635,615 shares, compared to its average volume of 825,482. The business has a 50 day moving average of $259.14 and a 200 day moving average of $231.05. The stock has a market cap of $27.02 billion, a price-to-earnings ratio of 49.43, a price-to-earnings-growth ratio of 1.88 and a beta of 1.51. The company has a debt-to-equity ratio of 1.04, a current ratio of 0.67 and a quick ratio of 0.67. Equifax has a 12-month low of $159.95 and a 12-month high of $275.10.

Equifax (NYSE:EFX - Get Free Report) last announced its earnings results on Wednesday, April 17th. The credit services provider reported $1.50 EPS for the quarter, beating the consensus estimate of $1.44 by $0.06. The company had revenue of $1.39 billion during the quarter, compared to the consensus estimate of $1.40 billion. Equifax had a net margin of 10.36% and a return on equity of 19.40%. The firm's revenue for the quarter was up 6.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.43 earnings per share. As a group, analysts expect that Equifax will post 7.53 EPS for the current year.

Hedge Funds Weigh In On Equifax

A number of hedge funds have recently bought and sold shares of EFX. KB Financial Partners LLC purchased a new stake in shares of Equifax during the 3rd quarter valued at about $25,000. Wetzel Investment Advisors Inc. purchased a new stake in Equifax during the 4th quarter valued at approximately $25,000. Householder Group Estate & Retirement Specialist LLC purchased a new stake in Equifax during the 3rd quarter valued at approximately $27,000. Eagle Bay Advisors LLC purchased a new stake in Equifax during the 2nd quarter valued at approximately $29,000. Finally, Geneos Wealth Management Inc. grew its holdings in Equifax by 70.8% during the 3rd quarter. Geneos Wealth Management Inc. now owns 193 shares of the credit services provider's stock valued at $35,000 after buying an additional 80 shares in the last quarter. Hedge funds and other institutional investors own 96.20% of the company's stock.

Equifax Company Profile

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.